Immediate Impact

1 by Nobel laureates 2 from Science/Nature 55 standout
Sub-graph 1 of 20

Citing Papers

New immune cell engagers for cancer immunotherapy
2024 Standout
In Situ Piezoelectric‐Catalytic Anti‐Inflammation Promotes the Rehabilitation of Acute Spinal Cord Injury in Synergy
2024 Standout
1 intermediate paper

Works of Luke Coyle being referenced

Open-Label, Phase 2 Study of Blinatumomab As Second Salvage Therapy in Adults with Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma
2018
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
2007
and 1 more

Author Peers

Author Last Decade Papers Cites
Luke Coyle 610 331 363 471 45 1.5k
Susan Geyer 474 537 426 445 72 2.2k
Massimo Iacobelli 1056 262 338 404 53 1.8k
Richard L. Humphrey 460 297 681 344 59 1.7k
Robert B. Howe 619 203 498 179 38 1.6k
Peter Browett 708 504 440 352 90 1.7k
Emmanuel C. Besa 998 168 422 479 69 1.7k
Ken Toba 393 296 508 590 97 1.6k
Edward J. Fitzsimons 678 258 476 224 70 1.8k
Julie Rayes 674 338 395 548 45 1.6k
Brian J. Skaggs 568 242 401 814 33 2.0k

All Works

Loading papers...

Rankless by CCL
2026